Completed PHASE3 INTERVENTIONAL 2-arm NCT01656512

Zometa Study in Pediatric Acute Lymphoblastic Leukemia

Analysis of Outcome of Bisphosphonate Use in Children With ALL- Case Controlled Study

Sponsor: Children's Cancer Hospital Egypt 57357

Interventions calcium & vitamin D zolendronic acid

Updated 7 times since 2017 Last updated: Apr 15, 2018 Started: Oct 31, 2011 Primary completion: Jan 31, 2014 Completion: Aug 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01656512, this PHASE3 trial focuses on Osteoporosis and remains completed. Sponsored by Children's Cancer Hospital Egypt 57357, it has been updated 7 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
May 2018 — Jun 2018 [monthly]

Completed PHASE3

Phase: NA → PHASE3

▶ Show 2 earlier versions

Feb 2017 — May 2018 [monthly]

Completed NA

Status: Suspended → Completed
Jan 2017 — Feb 2017 [monthly]

Suspended NA

First recorded

Oct 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Children's Cancer Hospital Egypt 57357

Data source: Children's Cancer Hospital Egypt 57357

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cairo, Egypt